News Category
German sports nutrition brand TNT heads to ECRM to build U.S. retail partnerships, leveraging its 500,000-customer base and diverse portfolio to enter...
VERAXA Biotech's appointment of Dr. Christoph Erkel as Chief Scientific Officer signals a strategic push to advance its BiTAC® T-cell engager platform...
Earth Science Tech Inc. reports significant revenue growth and a stronger balance sheet, positioning itself as a self-sustaining, vertically integrate...
SS Innovations International expands its robotic cardiac surgery footprint to Sri Lanka, signaling growing global adoption of its SSi Mantra system.
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, moves toward a Phase 2 trial in multiple sclerosis after FDA clearance of its IND appli...
Quantum BioPharma receives FDA clearance for a phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis drug designed to shield and potentially ...
Quantum BioPharma's Lucid-MS, the first drug designed to protect and rebuild myelin, receives FDA clearance for a Phase 2 trial, offering new hope for...
SS Innovations International announced a 79% increase in procedures using its SSi Mantra surgical robot and a 42% expansion of its installed base, sig...
Helus Pharma CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, highlighting the...
Onco-Innovations' CMO discussed the company's lead drug candidate ONC010, a novel PNKP inhibitor with dual selectivity mechanisms, and its planned fir...
Quantum BioPharma's FDA clearance of its IND for Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, enables a Phase 2 trial in multiple sclerosis...
American Fusion advances its Texatron fusion program into active testing with peak pressures of 100,000 atmospheres, signaling progress toward commerc...
American Fusion has advanced its Texatron fusion program into active testing with record pressures, potentially accelerating the path to commercial fu...
Visory Health's recognition highlights its innovative, open workplace culture that drives its mission to make prescriptions affordable for all America...
Earth Science Tech leverages vertical integration and dual-segment targeting to create a durable, self-sustaining healthcare business model.
Kairos Pharma's CEO will present at the H.C. Wainwright conference, underscoring the company's clinical advancements in targeting CD105 to reverse dru...
The World Gold Council warns that gold prices may retreat further as momentum diminishes, amid conflicting signals from the U.S. Treasury and Federal ...
The article highlights the often-overlooked crisis in UTI diagnosis, emphasizing the need for improved diagnostic tools and the potential role of comp...
Nutriband's CEO participation in the Nasdaq LaB Biotech Summit underscores the company's strategic efforts to advance its abuse-deterrent fentanyl pat...
Silo Pharma's participation in the IPAC-RS forum underscores its commitment to advancing SPC-15, a nose-to-brain drug delivery system for PTSD, backed...
Quantum BioPharma's Lucid-MS, a novel myelin repair candidate for multiple sclerosis, received FDA clearance for Phase 2 trials, marking a significant...
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protective multiple sclerosis drug candidate, has received FDA clearance to begin a Phase 2 clin...
Helus Pharma's CEO participation in a key investment conference underscores the company's advancing clinical programs and its potential to reshape men...
The conference aims to connect investors with under-covered growth and life sciences firms, highlighting the importance of direct engagement in today’...
GeoVax supports the new global mpox vaccine stockpile and emphasizes its GEO-MVA candidate's readiness to contribute to a diversified vaccine supply f...
Voyageur Pharmaceuticals advances its iodine production feasibility study with Bayer, receiving a $1 million milestone payment, highlighting progress ...
The August Wellness Index Report highlights the critical role of translational longevity in bringing scientific breakthroughs to patients, featuring e...
Mitch Gould, founder and CEO of Nutritional Products International, will attend the ECRM session to leverage face-to-face meetings with retailers, emp...
Treasury Secretary Bessent's admission of inside information on the yen underscores a new era where policymakers act as market participants, with impl...
The Shenzhen-Hong Kong-Guangzhou cluster leads the world in innovation for another year, underscoring the Greater Bay Area's dominance and highlightin...
Greenland Mines (GRML) announces a Q4 biotech spin-off and key milestones, including Nasdaq compliance and the Sarfartoq acquisition, as it transition...
Nano-X Imaging's new distribution agreement with Associated X-Ray Imaging Corp. aims to increase access to its Nanox.ARC system in New England, potent...
SS Innovations International is expanding its SSi Mantra surgical robotic system internationally, with strong revenue growth and an expanding installe...
VERAXA Biotech's appointment of seasoned financial executive Raju Willener as CFO signals a strategic move to bolster its capital strategy and advance...
Scinai Immunotherapeutics refocuses its R&D portfolio after terminating a license agreement, prioritizing its NanoAb platform and CDMO business to enh...
Onco-Innovations is advancing its oncology pipeline by securing manufacturing capabilities, IND-enabling activities, partnerships, and funding, markin...
Wearable Devices will present its AI-powered neural sensing layer at Physical AI 2026, which could enhance humanoid robotics by providing intent and m...
OS Animal Health's presentation at the Moody Capital conference highlights its strategic push to advance OST-HER2 for canine osteosarcoma, underscorin...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS, a first-in-class remyelinating agent, marks a pivotal step toward potentially treat...
Researchers at Washington University School of Medicine have advanced laser interstitial thermal therapy (LITT) as a less invasive brain cancer treatm...
Ocumetics Technology Corp. has initiated patient recruitment for Group Two of its clinical study, moving beyond safety to evaluate the vision performa...
Quantum BioPharma's FDA clearance to test Lucid-MS in phase 2 trials marks a potential breakthrough in MS treatment by targeting myelin repair, not ju...
NanoViricides has registered its Phase II Ebola trial for NV-387 Oral Gummies in the DRC, marking a significant step in developing a broad-spectrum an...
Nutriband received a USPTO Notice of Publication for trademarks related to its lead abuse-deterrent fentanyl patch, moving closer to commercial launch...
Greenland Mines announced a Q4 2026 biotech spin-off and completed the Sarfartoq acquisition, with a high-case NPV of $2.05B, positioning itself as a ...
Quantum BioPharma has received FDA clearance to begin a Phase 2 trial of its investigational multiple sclerosis drug Lucid-MS, marking a critical step...
Quantum BioPharma's FDA clearance to begin a Phase 2 trial of Lucid-MS, a first-in-class PAD2 inhibitor targeting demyelination in MS, marks a pivotal...
Quantum BioPharma's FDA clearance for Lucid-MS Phase 2 trial marks a significant step toward a targeted therapy for multiple sclerosis, potentially sh...
